Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KMT2A | Q03164 | 1/20 | 0.45 |
| ▸ | CA1 | P00915 | 1/20 | 0.44 |
| ▸ | CA2 | P00918 | 1/20 | 0.44 |
| ▸ | CA7 | P43166 | 1/20 | 0.44 |
| ▸ | CTSK | P43235 | 5/20 | 0.43 |
| ▸ | CTSS | P25774 | 4/20 | 0.43 |
| ▸ | CTSL | P07711 | 2/20 | 0.43 |
| ▸ | CTSB | P07858 | 1/20 | 0.43 |
| ▸ | GLS | O94925 | 1/20 | 0.41 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.40 |
| ▸ | GLA | P06280 | 2/20 | 0.38 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.38 |
| ▸ | GAA | P10253 | 1/20 | 0.38 |
| ▸ | MAPT | P10636 | 1/20 | 0.38 |
| ▸ | HPGD | P15428 | 1/20 | 0.38 |
| ▸ | PSENEN | Q9NZ42 | 1/20 | 0.38 |
| ▸ | CA12 | O43570 | 1/20 | 0.38 |
| ▸ | CA14 | Q9ULX7 | 1/20 | 0.38 |
| ▸ | CAPN1 | P07384 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21952754 | 1.00 | KMT2A (0.45) | KMT2ACA1CA2CA7CTSK | |
| SCHEMBL19209704 | 0.94 | CA1 (0.49) | KMT2ACA1CA2CA7CTSK | |
| SCHEMBL21187798 | 0.94 | CA1 (0.49) | KMT2ACA1CA2CA7CTSK | |
| SCHEMBL16181845 | 0.90 | KMT2A (0.42) | KMT2ACA1CA2CA7CTSK | |
| SCHEMBL15663571 | 0.86 | CYP1A2 (0.49) | KMT2ACA1CA2CA7CTSK | |
| SCHEMBL21065379 | 0.86 | CYP1A2 (0.49) | KMT2ACA1CA2CA7CTSK | |
| SCHEMBL21065384 | 0.86 | CYP1A2 (0.49) | KMT2ACA1CA2CA7CTSK | |
| SCHEMBL21065378 | 0.86 | CYP1A2 (0.49) | KMT2ACA1CA2CA7CTSK | |
| SCHEMBL29918031 | 0.85 | KMT2A (0.47) | KMT2ACA1CA2CA7CTSK | |
| SCHEMBL29918107 | 0.85 | KMT2A (0.47) | KMT2ACA1CA2CA7CTSK |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11370747-B2 | Method for producing amide compound | CHUBU UNIVERSITY EDUCATIONAL FOUNDATION (JP) | 2022-06-28 | — | — | US | disclosed |
| US-20200131117-A1 | METHOD FOR PRODUCING AMIDE COMPOUND | CHUBU UNIVERSITY EDUCATIONAL FOUNDATION (JP) | 2020-04-30 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11370747-B2 | Method for producing amide compound | NAAA, ASNS, GLUL | KMT2A 854/4885CA1 174/4885CA2 755/4885 |
| US-20200131117-A1 | METHOD FOR PRODUCING AMIDE COMPOUND | NAAA, ASNS, GLUL | KMT2A 854/4885CA1 174/4885CA2 755/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.